Commercially available serum replacements are often used in cell culture as a cheaper and less variable substitute for fetal bovine serum (FBS). The growth of porcine reproductive and respiratory syndrome virus (PRRSV) isolates in CRL11171 cells maintained in a medium supplemented with FBS was compared with virus propagation in the same cell line maintained in the same medium with a serum replacement. The PRRSV replicated significantly better when the cell culture medium was supplemented with FBS. The results of this study have implications for the use of serum replacement-supplemented medium for PRRSV diagnosis by virus isolation.
Porcine reproductive and respiratory syndrome virus (PRRSV) was first isolated in Europe on primary porcine alveolar macrophages (PAM) and was designated Lelystad virus. 9 The first US PRRSV isolate was isolated on a continuous cell line, ATCC CL2621. 3 In addition to PAM cultures 9 and the CL2621 cell line, 3 the MARC 145 7 and ATCC CRL11171 8 cell lines also support PRRSV replication. Both US and European PRRSV isolates replicate well in PAM cultures, but the difficulties and expense in obtaining these cells limit their use. Therefore, a continuous cell line is most often used to isolate and propagate PRRSV.
Virus isolation is a commonly used method for the detection of PRRSV infection in many diagnostic laboratories. Clinical and diagnostic laboratories that maintain cell cultures for virus isolation can be affected by the cost and availability of fetal bovine serum (FBS). 6 Because FBS carries the risk of contamination with bovine viruses, batch-to-batch variation, and increased expense, a serum replacement is desirable, particularly in clinical and diagnostic settings. Commercially available serum replacements are often used as a substitute for FBS.
Previous studies of serum replacements have shown variable results in their ability to support the growth of cell cultures and to replicate virus. Thus, the adaptability of cell lines to serum replacements and the capability of the cell line to propagate virus must be examined on an individual basis. 2, 6 The variation in PRRSV propagation on various cell types has been reported, but differences due to medium or medium supplement changes have not been reported. 1, 7 In this study, the growth of PRRSV isolates in CRL11171 a cell cultures maintained with either FBS or a serum replacement b was compared.
To compare the replication of PRRSV with both supplements, CRL11171 cells were split into 2 populations, 1 maintained in Dulbecco's modified Eagle medium (DMEM) containing 10% FBS and the other maintained in DMEM supplemented with 10% serum replacement. After 3 passages in the respective supplemented medium, confluent monolayers of both cell populations were grown on 12-well plates.
The cells showed no difference in growth rates or morphology regardless of the serum supplement used (data not shown). The CRL11171 monolayers were infected in triplicate with the 11th passage of VR-2385, a well-characterized virulent US PRRSV isolate, at 0.05 and 0.005 multiplicity of infection (moi). 4, 5 After 1 hour adsorption, the inoculum was removed and replaced with DMEM plus 2% of the appropriate serum. At 24, 48, 72, 96, and 120 hours postinfection, triplicate wells of cells grown in each serum/serum replacement and at each moi were harvested by completely scraping each well, and the entire cell/supernatant mixture was frozen overnight at Ϫ80 C.
The virus stocks were thawed and clarified by centrifugation at 1,100 ϫ g for 10 minutes. The virus was then serially diluted at 10-fold dilutions, and 100 l was used to infect monolayers of FBS-maintained CRL11171 cells on 96-well plates in quadruplicate. After 1 hour adsorption, 100 l of DMEM plus 2% FBS was added to each well, and the plates were incubated for 48 hours. The 50% tissue culture infectivity dose (TCID 50 ) was then determined by indirect fluorescent antibody testing using a monoclonal antibody, B 7 ef 11 , c which recognizes the nucleocapsid protein. 10 The growth curves were then repeated using the same virus stock.
The PRRSV isolate VR-2385 replicated to a higher titer in cells supplemented with FBS as compared with the cells grown in the serum replacement. The maximum titer of virus grown in serum replacement was 1.5-2 log 10 lower than that of the FBS-grown virus. VR-2385 consistently grew to at least 1 log 10 higher titer in FBS than in serum replacement from 24 to 120 hours postinfection ( Fig. 1 ). Multiple linear regression was used to determine the significance of growth medium, time point, and experimental replicate on PRRSV growth. Each of these factors had a significant (P Յ 0.0001) effect on virus growth; however, the difference in serum treatment had the greatest effect at each moi tested. The difference in the VR-2385 titer in the 2 growth conditions is a little larger at most time points with the lower moi of 0.005, with an average 99% reduction in titer, as compared with a 97.8% reduction at an moi of 0.05 (Table 1 ). This finding suggests that the growth of PRRSV in serum replacement-supplemented cells may be more affected by adverse growing conditions, such as low numbers of infectious virus particles.
To confirm that the differences in PRRSV growth rate were not unique for isolate VR-2385, another isolate, ISU-79, was used to infect CRL11171 cells at 0.05 moi. ISU-79 had approximately a 1.5 log 10 higher titer when grown in FBS-supplemented cells than when grown in serum replacement-supplemented cells at all 5 time points (Fig. 2) . Thus, the difference in serum used in cell propagation had a significant (P Յ 0.0001) effect on the growth of Ͼ1 US PRRSV isolate, based on analysis by multiple linear regression.
PRRSV is commonly propagated on continuous cell lines. Clinical and diagnostic laboratories may use serum replacements in the maintenance of these cell lines to decrease costs and variability in the cultures. The adaptability of cell lines and viruses to commercial serum replacements has been var-iable and must be examined on an individual basis. In this study, the growth of 2 PRRSV isolates in the CRL11171 cell line was compared for 2 different supplements, FBS and serum replacement. The results of this study show that PRRSV titers were consistently higher when the virus was propagated in cells grown in FBS than when cells were grown in a serum replacement. The enhancement of viral propagation seen in FBS may be greater at lower multiplicites of infection, as would commonly be seen in virus isolation for the diagnosis of field cases. This increase in viral titers in FBS-supplemented medium, as compared with medium supplemented with serum replacement, was consistent for 2 isolates. These observations suggest that the choice of serum supplement in PRRSV propagation can influence viral titers, which may have implications for PRRSV diagnosis by virus isolation.
